Chevallier P - Search Results

1

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.

Chevallier P, Hunault-Berger M, Larosa F, Dauriac C, Garand R, Harousseau JL. Chevallier P, et al. Leuk Res. 2009 Aug;33(8):1124-6. doi: 10.1016/j.leukres.2008.09.030. Epub 2008 Nov 5. Leuk Res. 2009. PMID: 18990444 Clinical Trial.

2

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.

Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahé B, Hamidou M, Maisonneuve H, Moreau P, Jardel H, Harousseau JL, Bataille R, Garand R. Chevallier P, et al. Br J Haematol. 2002 Jan;116(1):142-50. doi: 10.1046/j.0007-1048.2001.3205.x. Br J Haematol. 2002. PMID: 11841407 Free article.

3

Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.

Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M. Spisek R, et al. Among authors: chevallier p. Cancer Res. 2002 May 15;62(10):2861-8. Cancer Res. 2002. PMID: 12019165

4

Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.

Chevallier P, Robillard N, Wuilleme-Toumi S, Méchinaud F, Harousseau JL, Avet-Loiseau H. Chevallier P, et al. Haematologica. 2004 Nov;89(11):1399-401. Haematologica. 2004. PMID: 15531467

5

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.

Vigouroux S, Morin O, Moreau P, Méchinaud F, Morineau N, Mahé B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N. Vigouroux S, et al. Among authors: chevallier p. Clin Infect Dis. 2005 Feb 15;40(4):e35-7. doi: 10.1086/427752. Epub 2005 Jan 25. Clin Infect Dis. 2005. PMID: 15712069

6

Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.

Chevallier P, Roland V, Mahé B, Juge-Morineau N, Dubruille V, Guillaume T, Vigouroux S, Moreau P, Milpied N, Garand R, Avet-Loiseau H, Harousseau JL. Chevallier P, et al. Leuk Res. 2005 Sep;29(9):1003-7. doi: 10.1016/j.leukres.2005.02.005. Epub 2005 Apr 8. Leuk Res. 2005. PMID: 16038726

7

Re-administration of a combination of chemotherapy + Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicity.

Chevallier P, Touzeau C, Ayari S, Guillaume T, Harousseau JL, Delaunay J. Chevallier P, et al. Leuk Res. 2008 Aug;32(8):1321-2. doi: 10.1016/j.leukres.2007.09.009. Epub 2007 Oct 29. Leuk Res. 2008. PMID: 18029013

8

Two cases of acute lymphoblastic leukaemia following acute myeloid leukaemia.

Chevallier P, Al Nawakil C, Vigouroux S, Talmant P, Harousseau JL, Garand R. Chevallier P, et al. Leuk Res. 2008 Jun;32(6):1001-3. doi: 10.1016/j.leukres.2007.11.014. Epub 2008 Feb 21. Leuk Res. 2008. PMID: 18093650 No abstract available.

9

Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.

Royer PJ, Bougras G, Ebstein F, Leveque L, Tanguy-Royer S, Simon T, Juge-Morineau N, Chevallier P, Harousseau JL, Gregoire M. Royer PJ, et al. Among authors: chevallier p. Exp Hematol. 2008 Mar;36(3):329-39. doi: 10.1016/j.exphem.2007.11.001. Epub 2008 Jan 22. Exp Hematol. 2008. PMID: 18207305 Free article.

10

Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.

Chevallier P, Mohty M, Lioure B, Michel G, Contentin N, Deconinck E, Bordigoni P, Vernant JP, Hunault M, Vigouroux S, Blaise D, Tabrizi R, Buzyn A, Socie G, Michallet M, Volteau C, Harousseau JL. Chevallier P, et al. J Clin Oncol. 2008 Oct 20;26(30):4940-3. doi: 10.1200/JCO.2007.15.6315. Epub 2008 Jul 7. J Clin Oncol. 2008. PMID: 18606981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

885 results

Search Page